Dr Miles is a cellular and molecular biologist with research expertise in cancer biology, infectious diseases and cell death signaling pathways. He is interested in understanding the pathophysiology of respiratory viruses and how host inflammatory responses are altered during infection, which may contribute to disease progression.

Sophie Miller is a PhD student specialising in clinical and molecular microbiology at Flinders University and the South Australian Health and Medical Research Institute. Her research focuses on the impact of health-care on the gut and respiratory microbiome, and how these complex relationships influence clinical outcomes.

Luke is a basic physician trainee with an interest in respiratory medicine and transplantation. He is a General Sir John Monash Scholarship recipient through which he conducted COVID-19 lung immunopathology research in the UK, alongside exposures in ex vivo lung perfusion, nocturnal respiratory monitoring and international organ donation auditing practice.

Renee has just recently completed her PhD titled Exploring the potential of phage therapy for people with P. aeruginosa lung infection

Dr. Taylor heads the Respiratory Health Group within the Microbiome and Host Health Programme at SAHMRI. His research program investigates airway pathophysiology in people with chronic lung diseases, in particular, the contribution of the airway microbiome to disease onset, progression and treatment efficacy

Dr. Leshan Wannigama is an infectious disease physician-scientist at the Center of Excellence in Antimicrobial Resistance and Stewardship Research, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand. He conducts research in a clinically-relevant context, focuses on chronic lung infections, and explores Novel therapies, Antimicrobial resistance, and clinical and epidemiological surveillance.